DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Apr 28, 2022 · 4y ago · Accession 0001308179-22-000294
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Apr 28, 2022
- Report date
- Jun 24, 2022
- Document
- lrare2022_def14a.htm
- Size
- 2.2 MB